Comparative study of laparoscopic ovarian drilling and medical treatment in polycystic ovarian disease


  • Hema Verma Department of Obstetrics and Gynaecology T.S Misra medical college and Hospital, Amausi, Lucknow, Uttar pradesh, India
  • Prachi Srivastava Department of Obstetrics and Gynaecology T.S Misra medical college and Hospital, Amausi, Lucknow, Uttar pradesh, India



Clomiphene citrate, Hyperandrogenemia, Laparoscopic ovarian drilling, Oligomenorrhoea, Ovulation, Polycystic ovarian disease


Background: To evaluate the result after medical treatment and laparoscopic ovarian drilling in PCOS patients and to compare the results of these two methods.

Methods: In this prospective study 50 women with polycystic ovarian disease, were divided into two group,25 women received medical treatment and 25 women received surgical (laparoscopic ovarian drilling) treatment. Effect of treatment on ovulation, menstruation, fertility and androgen level was determined 3 month after therapy.

Results: There was significant increase in ovulation and fertility, decrease in androgen levels and decrease in LH/FSH in individual groups when compared with pretreatment levels but difference between groups A and B was not statistically significant for these parameters.

Conclusions: Medical treatment and laparoscopic ovarian drilling are equally effective in treating the women of polycystic ovarian disease. Result of both the treatment are similar in this study. However medical treatment should be the first line therapy, it has significant benefit for use in OPD, low cost, no hospital stays and convenience to the patient.


National institutes of department of health and human service. Beyond infertility PCOS NIH 2008,8:58-63.

Balen A. Pathogenesis of polycystic ovary syndrome- the enigma unravels?. The Lancet. 1999;354(9183):966-7.

Revised 2003 consensus on diagnostic criteria and long term health risk related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004, 19:41-47.

McFarland C. Treating polycystic ovary syndrome and infertility. MCN: Am J Maternal/Child Nursing. 2012;37(2):116-21.

Birdsall MA, Farquhar CM, White HP. Association between polycystic ovary and extent of coronary artery disease in women having cardiac catheterization. Ann Intern Med. 1997;126:32-5.

Guzick DS, Tabbott EO. Sutton Tyrrell K, Herzog HC, Kullr LH, wolfson SK jr. Carotid atherosclerosis in women with polycystic ovary syndrome. Initial results from a case control study. Am J. Obstet Gynecol. 1996;174:1224-9.

Moran LJ, Brinkworth G, Noakes M, Norman RJ. Effects of lifestyle modification in polycystic ovarian syndrome. Report. Biomed Online. 2006;12:569-78.

Kahn JA, Gordon GM polycystic ovary syndrome. Adolesc Med. 1999;10:321-36.

Wiegratz I, Kuhl H. Long-cycle treatment with oral contraceptives. Drugs. 2004;64(21):2447-62.

Guzick PS, Polycystic ovary syndrome. Obstet Gynecol. 2004;103:181-93 .

Plosker SM. Polycystic ovary syndrome and insulin resistance. Med health R I. 2003;86:12-5.

Cheang KI, Nestler JE. Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome?. Reproductive Biomed Online. 2004;8(4):440-7.

Essah PA, Apridonidze T, Iuorno MJ, Nestler JE. Effects of short-term and long-term metformin treatment on menstrual cyclicity in women with polycystic ovary syndrome. Fertil Steril. 2006;86(1):230-2.

Baillargeon JP. Use of insulin sensitizer in polycystic ovarian syndrome. Curr Opin Investing Drugs. 2005;6:1012-22.

Franks S. Assessment and management of anovulatory infertility in polycystic ovary syndrome. Endocrinol Metabol Clinics. 2003;32(3):639-51.

Pritts EA. Treatment of the infertile patient with polycystic ovarian syndrome. Obstetr Gynecol Survey. 2002;57(9):587-97.

Leclair C, Patton PE. Advances in polycystic ovary syndrome treatment: metformin and ovarian diathermy. Current women's health reports. 2002;2(5):333-7.

Saleh AM, Khalil HS. Review of nonsurgical and surgical treatment and role of insulin sensitizing agent in the management of infertile women with polycystic ovary syndrome. Acta Obstet Gynecol Scand. 2004;83:614-21.

Nestler JE, Jakubowicz DJ. Decrese in ovarian cytochrome p450c17 alpha activity and serum free testosterone after reduction on insulin secretion in polycystic ovary syndrome. N Engl J Med. 1996;335:617-23.

Farquhar C, Brown J, Marjoribanks J. Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane database of systematic reviews. 2012(6).

Gomel V, Yarali H. Surgical treatment of PCOS associated with infertility. Reprod Biomed Online. 2004;9(1):35-42.

Gobar Kovacs, Hellen buckler, Mohanbangah. Treatment of anovulation due to PCOS by laparoscopic ovarian electrocautery BJOG. 1991.

Palomba S, Orio Jr F, Falbo A, Russo T, Caterina G, Manguso F, et al. Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligo‐anovulatory CC‐resistant women with polycystic ovary syndrome. Clinic Endocrinol. 2005;63(6):631-5.

Hamed HO, Hasan AF, Ahmed OG, Ahmed MA. Metformin versus laparoscopic ovarian drilling in clomiphene‐and insulin‐resistant women with polycystic ovary syndrome. International J Gynecol Obstetr. 2010;108(2):143-7.

Bayram N, Van Wely M, Kaaijk EM, Bossuyt PM, van der Veen F. Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial. BMJ. 2004;328(7433):192.

Pirwany I, Tulandi T. Laparoscopic treatment of polycystic ovaries: is it time to relinquish the procedure?. Fertil steril. 2003 Aug 1;80(2):241-51.






Original Research Articles